226 related articles for article (PubMed ID: 15976487)
1. Human defensins in Crohn's disease.
Wehkamp J; Fellermann K; Stange EF
Chem Immunol Allergy; 2005; 86():42-54. PubMed ID: 15976487
[TBL] [Abstract][Full Text] [Related]
2. Crohn's disease: a defensin deficiency syndrome?
Fellermann K; Wehkamp J; Herrlinger KR; Stange EF
Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):627-34. PubMed ID: 12840673
[TBL] [Abstract][Full Text] [Related]
3. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
Wehkamp J; Schmid M; Fellermann K; Stange EF
J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
[TBL] [Abstract][Full Text] [Related]
4. Defensin-immunology in inflammatory bowel disease.
Wehkamp J; Stange EF; Fellermann K
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
[TBL] [Abstract][Full Text] [Related]
5. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
[TBL] [Abstract][Full Text] [Related]
6. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
Wehkamp J; Stange EF
Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
8. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
[TBL] [Abstract][Full Text] [Related]
9. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.
Wehkamp J; Wang G; Kübler I; Nuding S; Gregorieff A; Schnabel A; Kays RJ; Fellermann K; Burk O; Schwab M; Clevers H; Bevins CL; Stange EF
J Immunol; 2007 Sep; 179(5):3109-18. PubMed ID: 17709525
[TBL] [Abstract][Full Text] [Related]
10. Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease.
Wang G; Stange EF; Wehkamp J
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):1049-57. PubMed ID: 18039087
[TBL] [Abstract][Full Text] [Related]
11. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
[TBL] [Abstract][Full Text] [Related]
12. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
Peyrin-Biroulet L; Chamaillard M
J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of chronic inflammatory bowel diseases].
Kreisel W
Praxis (Bern 1994); 2006 Dec; 95(50):1965-73. PubMed ID: 17256276
[TBL] [Abstract][Full Text] [Related]
14. Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease.
Wehkamp J; Koslowski M; Wang G; Stange EF
Mucosal Immunol; 2008 Nov; 1 Suppl 1():S67-74. PubMed ID: 19079235
[TBL] [Abstract][Full Text] [Related]
15. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
[TBL] [Abstract][Full Text] [Related]
16. [The role of defensins in the pathogenesis of chronic-inflammatory bowel disease].
Schmid M; Fellermann K; Wehkamp J; Herrlinger K; Stange EF
Z Gastroenterol; 2004 Apr; 42(4):333-8. PubMed ID: 15095125
[TBL] [Abstract][Full Text] [Related]
17. Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype.
Bevins CL; Stange EF; Wehkamp J
Gut; 2009 Jun; 58(6):882-3; discussion 883-4. PubMed ID: 19433600
[No Abstract] [Full Text] [Related]
18. Nod2: a key regulator linking microbiota to intestinal mucosal immunity.
Biswas A; Petnicki-Ocwieja T; Kobayashi KS
J Mol Med (Berl); 2012 Jan; 90(1):15-24. PubMed ID: 21861185
[TBL] [Abstract][Full Text] [Related]
19. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis.
Ogura Y; Lala S; Xin W; Smith E; Dowds TA; Chen FF; Zimmermann E; Tretiakova M; Cho JH; Hart J; Greenson JK; Keshav S; Nuñez G
Gut; 2003 Nov; 52(11):1591-7. PubMed ID: 14570728
[TBL] [Abstract][Full Text] [Related]
20. Crohn's disease--defect in innate defence.
Gersemann M; Wehkamp J; Fellermann K; Stange EF
World J Gastroenterol; 2008 Sep; 14(36):5499-503. PubMed ID: 18810765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
